George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 449 shares at $42.32 ($19K) on 2021-04-12, disclosed to the SEC on 2021-04-14.
Scheduled sale ($19k) by EVP, Investments & GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.32 | 89 | $4K | 19.8% |
| 2 | $42.32 | 360 | $15K | 80.2% |
| Total | $42.32 avg | 449 | $19K | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |